Successive pancytopenia as indication for myeloma treatment – a rare case of visceral leishmaniasis

Papakonstantinou, G; Koutsis, D; Spyridonidis, A

dc.contributor.author	Papakonstantinou, G	en
dc.contributor.author	Koutsis, D	en
dc.contributor.author	Spyridonidis, A	en
dc.date.accessioned	2014-03-01T01:59:33Z
dc.date.available	2014-03-01T01:59:33Z
dc.date.issued	2010	en
dc.identifier.uri	https://dspace.lib.ntua.gr/xmlui/handle/123456789/28967
dc.subject	Multiple Myeloma	en
dc.subject	Visceral Leishmaniasis	en
dc.subject	Amphotericin B	en
dc.title	Successive pancytopenia as indication for myeloma treatment – a rare case of visceral leishmaniasis	en
heal.type	journalArticle	en
heal.identifier.primary	10.1007/s12254-010-0229-0	en
heal.identifier.secondary	http://dx.doi.org/10.1007/s12254-010-0229-0	en
heal.publicationDate	2010	en
heal.abstract	Summary Symptoms and successive pancytopenia in patients with known smouldering multiple myeloma lead unavoidably to the diagnosis of a therapy requiring symptomatic myeloma. Nevertheless, additional diseases can appear in a pre-existing smouldering myeloma and slowly change the physical course of the disease imitating myeloma-related symptoms and organ dysfunction. An unneeded, faulty systemic therapy for multiple myeloma in these cases can have	en
dc.identifier.doi	10.1007/s12254-010-0229-0	en